UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 5
May-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2305G24


Registration ID:
518041

Page Number

p164-p169

Share This Article


Jetir RMS

Title

A systematic review on role of Ivermectin in Rosacea

Abstract

Rosacea is a chronic, recurrent condition that can present as a number of different cutaneous symptoms. The centrofacial inflammatory dermatosis condition has serious financial, physical, and psychological effects. There are numerous topical, oral, and systemic therapies available. However, rosacea therapy is still challenging. It is difficult for both patients and clinicians because to the complex character of the disease and the lack of a thorough grasp of the pathogenesis. Recently, three clinical trials have provided evidence for the effectiveness of topical ivermectin cream in treating rosacea. Ivermectin exhibits a broad-spectrum anti-parasitic action, specifically targeting Demodex mites residing in the pilosebaceous units of individuals with papulopustular rosacea. The application of ivermectin cream successfully eradicates these mites. Ivermectin reduces cellular and humoral immune responses and has anti-inflammatory properties as well. The formation of inflammatory lesions in rosacea appears to be mostly influenced by inflammatory processes. Additionally, there is some proof that it exhibits antimicrobial efficacy against Chlamydia trachomatis and Myobacterium tuberculosis. According to recent clinical research on rosacea, ivermectin reduced the number of inflammatory lesions more effectively than a vehicle and had excellent tolerability. Ivermectin exhibits antibacterial, antiparasitic, anti-inflammatory, and antimicrobial properties. This article offers a thorough analysis of papulopustular rosacea treatment options, including the newly popular usage of 1% ivermectin cream. Topical 1% cream has emerged as a unique treatment for papulopustular rosacea. Although ivermectin 1% is a clinically effective drug, poor adherence remains a concern owing to topical use. Finally, the agent has the potential to be a useful medicine when used alone or in combination with other agents.

Key Words

Papulopustular, Phymatous, Demox mite, Erythematotelangiectatic

Cite This Article

"A systematic review on role of Ivermectin in Rosacea", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 5, page no.p164-p169, May-2023, Available :http://www.jetir.org/papers/JETIR2305G24.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A systematic review on role of Ivermectin in Rosacea", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 5, page no. ppp164-p169, May-2023, Available at : http://www.jetir.org/papers/JETIR2305G24.pdf

Publication Details

Published Paper ID: JETIR2305G24
Registration ID: 518041
Published In: Volume 10 | Issue 5 | Year May-2023
DOI (Digital Object Identifier):
Page No: p164-p169
Country: Dehradun, Uttarakhand, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000131

Print This Page

Current Call For Paper

Jetir RMS